Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China flag China · Delayed Price · Currency is CNY
17.12
-0.13 (-0.75%)
Apr 16, 2026, 10:00 AM CST

SHA:601607 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
32,72235,74430,51827,40122,390
Trading Asset Securities
10,3618,63310,1529,614-
Cash & Short-Term Investments
43,08344,37740,67037,01522,390
Cash Growth
-2.92%9.12%9.87%65.32%0.16%
Accounts Receivable
85,86682,21777,16370,18761,006
Other Receivables
2,2852,2372,3731,9571,786
Receivables
88,15084,45479,53672,14462,791
Inventory
45,35938,94436,62334,46027,104
Other Current Assets
3,8724,0485,6055,8944,209
Total Current Assets
180,464171,823162,434149,513116,494
Property, Plant & Equipment
19,28619,17518,00616,55015,793
Long-Term Investments
8,5889,83510,60311,47710,836
Goodwill
12,66611,14611,39311,33611,239
Other Intangible Assets
8,7445,6176,0516,2636,049
Long-Term Deferred Tax Assets
1,6401,6281,7171,5351,368
Long-Term Deferred Charges
103.24215.32785.22342.61259.23
Other Long-Term Assets
1,6581,770983.31,1191,397
Total Assets
233,149221,209211,973198,135163,436
Accounts Payable
61,40559,48354,63251,56641,995
Accrued Expenses
12,08010,63710,6389,5747,985
Short-Term Debt
49,12844,09641,61233,81131,592
Current Portion of Long-Term Debt
2,125191.82,3662,64933.44
Current Portion of Leases
585.37649.07596.67580.68545.04
Current Income Taxes Payable
875.12835.87809.8781.36721.16
Current Unearned Revenue
1,5041,5621,9712,2431,311
Other Current Liabilities
7,4968,5839,7479,4877,642
Total Current Liabilities
135,198126,038122,372110,69191,824
Long-Term Debt
4,2368,3315,7866,2607,158
Long-Term Leases
1,1491,3961,5501,3021,434
Long-Term Unearned Revenue
573.38550.99633.48534.582,349
Pension & Post-Retirement Benefits
43.6839.1638.8838.9139.01
Long-Term Deferred Tax Liabilities
1,945816.451,0161,049998.77
Other Long-Term Liabilities
215.98294.44250.14257.26566.09
Total Liabilities
143,361137,467131,646120,132104,369
Common Stock
3,7083,7083,7033,6982,842
Additional Paid-In Capital
29,64529,58829,18829,09816,071
Retained Earnings
43,02938,85436,12934,63930,591
Comprehensive Income & Other
-491.27-474.23-496.09-371.32-144.39
Total Common Equity
75,89171,67668,52467,06349,359
Minority Interest
13,89612,06711,80210,9399,707
Shareholders' Equity
89,78783,74280,32678,00259,066
Total Liabilities & Equity
233,149221,209211,973198,135163,436
Total Debt
57,22454,66451,91144,60240,762
Net Cash (Debt)
-14,141-10,287-11,241-7,587-18,372
Net Cash Per Share
-3.81-2.78-3.04-2.18-6.46
Filing Date Shares Outstanding
3,7083,7083,7033,6982,842
Total Common Shares Outstanding
3,7083,7083,7033,6982,842
Working Capital
45,26645,78540,06238,82224,670
Book Value Per Share
20.4619.3318.5018.1417.37
Tangible Book Value
54,48254,91351,08049,46432,071
Tangible Book Value Per Share
14.6914.8113.7913.3811.28
Buildings
14,46613,45510,95910,9419,698
Machinery
11,94311,3029,9829,0548,203
Construction In Progress
1,9942,1493,5702,7772,914
Source: S&P Global Market Intelligence. Standard template. Financial Sources.